Inhibitions of degradation of rat liver aldolase and lactic dehydrogenase by N-[N-(L-3-trans-carboxyoxirane-2-carbonyl)-L-leucyl] agmatine or leupeptin in vivo.
D000376:Agmatine / Q000031:analogs & derivatives / Q000494:pharmacology*; D000818:Animals; D002403:Cathepsins / Q000378:metabolism; D005634:Fructose-Bisphosphate Aldolase / Q000378:metabolism*; D006146:Guanidines / Q000494:pharmacology*; D007700:Kinetics; D007770:L-Lactate Dehydrogenase / Q000378:metabolism*; D007930:Leucine / Q000031:analogs & derivatives* / Q000494:pharmacology; D007976:Leupeptins / Q000494:pharmacology*; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008247:Lysosomes / Q000201:enzymology; D008297:Male; D009842:Oligopeptides / Q000494:pharmacology*; D051381:Rats
D006146:Guanidines; D007976:Leupeptins; D009842:Oligopeptides; D000376:Agmatine; D007770:L-Lactate Dehydrogenase; D002403:Cathepsins; D005634:Fructose-Bisphosphate Aldolase; D007930:Leucine; C024974:E 64